Tema Monopolies and Oligopolies ETF (TOLL) 뉴스

There is no desmis you moron fool! Stop lying. Tiktok is #1 an always will be, how can you lie, your mother must keep you in a closet all day with your noony in your mouth you fool

Dad'burn delightful display of doubtful detractors denying, debating and delirious!

I wish you were in this riding with us, unfortunately your crew decided to short it for years and you're going to feel the pain now. When we hit 25c, I hope you don't cry.

Wait; small company? lmao... dang 95 + employees isn't a small company.

Listen to this bro.
I am on no email lists and don't send email lists to anyone. Why? Cause I don't give a Flynn fuk.

That email, of stuff you said you wrote, and I believe it was sent to me. On a rare occasion zi get something sent to me. For instance this time. I don't mess

This blatant scam is done

Why no be just keep go up yet ?

.

w0w SEC🔥catches🎅🏿&👽ArtificiallyDeflating Prices 2Buy Shares"


6, 12, 2023 —

SEC charged investment adviser Sabby Management LLC & managing partner,Hal D. Mintz,w/ fraud in connection w/ a long running scheme involving misrepresenta

Wtf.

Security risk? Shrug. Trump flips on Tik Tok, because it's good for him.

PatriotTakes 🇺🇸
@patriottakes
Nikki Haley comes out against Trump’s plan to save TikTok, but won’t mention him by name

https://pbs.twimg.com/media/GgeV_fjXkAAgNe7?form

Roman, there could already be deals cut and the only thing we are waiting for now is approval. I actually believe this is the case and NWBO is under a gag order as BP would not want anything getting out until approval.

I am encouraged of what I see of the Histogram in the Weekly Chart showing that a new uptrend appears to be in the process of developing for the AMD share price.

Hopefully that is going to continue... and lead to a share price breakout soon.

We shall see.

Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months. They may also have understandably diverted some resources towards a successful MAA.

There is no regulatory "sufficiency" test, other than being better than the standard of care, if one exists. The article makes the case that blarcamesine is better than any approved AD drug. The FDA employs a risk/benefit analysis, and you want your drug candidate to more than offset any risks with

Changing the innards of a Chevy with Ferrari parts is a game changer. Learn about the Z06. Maybe you will appreciate what is set to occur when the cusip, name, and ticker changes in this instance. Ignorance is alive and well by folks old enough to know better. Sad!
https://www.detroitnews.com

Do you happen to have a link to that example you gave?

Is that the company claiming to make water from air lol ? I think I posted a lol awhile back.

Sorry to go off tilt..it's your fault. last one........killer:

https://www.youtube.com/watch?v=wwIJk0C0xY0

I remember a time when dimes and mojo were wildly praised for their claim that this stock would hit $1-$3 by June. Just like Robert Sullivan on their Facebook page.

It didn't.

Stop considering their posts. They know next to nothing.

By the way mojo - yo

which position will the EMA take? (conventional), or will they go outside the box and follow in the steps of the authors, making the MABs relevant to the decision. The EMA has hinted that they are not happy with the MABs. The question might be, will the EMA approve a drug that can show partial pos

A thug not even born here...smh.

Actually that's Smokey Robinson, of the baby boomer generation, but what's an education worth nowadays?

OTC is entering a golden age in 2025 - Chartmaster.

With news, BIEL could lead the way!